Research Archive
August 2022
Biopharma — Flash / Pricing Policy Call Takeaways & Updates to Exposure Analysis
View research noteJuly 2022
ALNY / Raising the Curtain for APOLLO-B — Power Analysis and Preview / Market Perform
View research noteJune 2022
MRK — Flash / ASCO Checkpoint Round-up: Early-Stage Debates and IO-IO / Outperform
View research noteMay 2022
Biopharma — Flash / TIGIT Disappoints in NSCLC; Numerical Improvement Leaves Some Hope
View research noteApril 2022
Biopharma / TIGIT Clinical Updates at AACR Incrementally Positive
View research noteMarch 2022
Healthcare Providers and Managed Care / Home Health: More Downside Risk to Ests Against an Improving Operating Backdrop
View research noteFebruary 2022
Biopharma / Key Takeaways from GHC Panel on Bispecifics vs. Cell Therapy in NHL and MM
View research noteJanuary 2022
Healthcare / Liquid Biopsy Nearing the Finish Line in CRC Screening Race
View research noteDecember 2021
Biopharma — Flash / Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 – Get Set for M&A
View research noteNovember 2021
Biopharma — Flash / Not to be Alarmist but Omicron is Alarming; Good for PFE & Other Incumbents
View research noteOctober 2021
Healthcare / Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact
View research noteSeptember 2021